Windlas Biotech Ltd. Members Approve Key Director Appointments
Windlas Biotech Limited announced today, March 20, 2026, that its members have approved the re-appointment of Mr. Ashok Kumar Windlass, Mr. Vivek Dhariwal, and Mr. Gaurav Gulati as Whole-time Director and Independent Directors, respectively, through a postal ballot.The results of the postal ballot, conducted via remote e-voting, were finalized on March 19, 2026. A total of 45,610 shareholders were eligible to vote.
Mr. Ashok Kumar Windlass was re-appointed as Whole-time Director effective May 3, 2026. Mr. Vivek Dhariwal and Mr. Gaurav Gulati were re-appointed as Independent Directors effective May 6, 2026.
Voting Results Summary
| Date of Postal Ballot Notice | February 5, 2026 |
|---|---|
| Cut-off date | February 13, 2026 |
| Voting Start Date & Time | February 18, 2026 (9:00 A.M.) |
| Voting End Date & Time | March 19, 2026 (5:00 P.M.) |
| Total number of shareholders | 45,610 |
Resolution Details
| Resolution No. 1: Re-appointment of Mr. Ashok Kumar Windlass |
|---|
| Total Valid Votes Polled: 15,320,885 |
| Votes in Favour: 13,065,352 (100.00%) |
| Resolution No. 2: Re-appointment of Mr. Vivek Dhariwal |
|---|
| Total Valid Votes Polled: 15,320,885 |
| Votes in Favour: 13,065,352 (100.00%) |
| Resolution No. 3: Re-appointment of Mr. Gaurav Gulati |
|---|
| Total Valid Votes Polled: 15,320,885 |
| Votes in Favour: 13,065,352 (100.00%) |
The voting results and the report from the Scrutinizer, Sandeep Joshi & Associates, are available on the company website (www.windlas.com) and on the MUFG Intime India Private Limited website (www.in.mpms.mufg.com).
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.